CETP and early-onset autosomal dominant Alzheimer disease: Although the exact mechanism remains unclear, CETP activity may promote Alzheimer’s disease through modifying cholesterol content, distribution, storage, or metabolism, which could be prevented by CETP inhibitors such as evacetrapib.